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PREFACE 
My ultimate goal is to become an Epidemiologist, and Public Health 
Educator/Humanitarian who focuses on reducing the mortality rates of breast and female-
related carcinomas in low-income communities as well as low- and middle-income countries 
(LMICs). Cancer epidemiology in women sparks my interest for various reasons. The first 
being, I find it extremely interesting how carcinoma is known as a complicated chronic 
disease due to the cancerous cells' intelligence in learning biochemical mechanisms and 
creating an infinite number of pathways for invading healthy cells. The second and third 
reasons correlate with one another. Both of my grandmothers had to receive breast 
lumpectomies. One of my grandmother's cancer was invasive and she had to undergo 
chemotherapy as a result. Even though they both survived, African American women are 
faced with a more aggressive subtype of breast cancer than any other race or ethnicity, triple-
negative breast cancer. I desire to be a part of the team who not only figures out why but 
determines treatment alternatives. Lastly, women are the creators of life. I strongly support 
the fact that health equity should be provided to those in need to combat the aggressive, 
chronic disease that is slowly engulfing women in countries with low healthcare resources.  
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ABSTRACT 
Background. South African’s (SA) breast cancer incidence rate is continually increasing (39 
per 100,000 (2012) versus 46.2 per 100,000 (2018) with trends towards later-stage diagnosis. 
In previous literature, breastfeeding has been assessed as a protective factor for breast cancer; 
however, the SA population experiences inconsistent breastfeeding trends, rates, and support 
services. Therefore, this study will evaluate the inverse association between breast cancer and 
breastfeeding history. Methods. Cases (breast cancer) and controls (mastalgia) were matched 
1:1 on clinical visit from May-August 2019 at Groote Schuur Hospital (GSH) in Cape Town, 
Western Cape, South Africa. Breastfeeding history, breast carcinoma diagnosis, and 
clinically relevant endocrinology data was extracted from GSH medical records. Bivariate 
conditional logistic regression (clogit) and 𝜒𝜒2 analyses compared predictor variables amongst 
breast cancer groups. Multivariable clogit models assessed the association between breast 
cancer diagnosis and breastfeeding history both unadjusted and adjusted for statistically and 
clinically relevant confounders. Results. Results. In a sample of 360 SA mothers (mean age= 
53 years old, SD= 14.36), 79% of breast cancer patients breast cancer breastfed while 75% of 
 
 
 
non-breast cancer patients breastfed, with the majority of the population (75%) having ever-
breastfed overall. When controlling for all other covariates, SA mothers with breastfeeding 
history did not have a lower risk of breast cancer compared to women who never breastfed 
with OR=1.29 (95% CI 0.52 – 3.23). Conclusion. This pilot study did not show a protective 
effect of breastfeeding on breast cancer diagnosis. However, it contributes to the theory that 
race, ethnicity, and detailed exposure/outcome statuses are essential to concluding 
statistically, biologically, and clinically significant results for the assessment of a dose-
response relationships.
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INTRODUCTION 
 
Breastfeeding Benefits and Barriers 
Breastfeeding is a natural and unique method of supplying infants with necessary 
nutrition in their early life that cannot be replaced by any other nutritional item, including 
infant formula, and encompasses health benefits for both the mother and baby (i.e. reduce 
pediatric mortality and morbidity, benefit neurocognitive functions, and are less likely to 
develop chronic diseases such as type 2 diabetes or become obese).1,2 To receive these 
benefits, the World Health Organization (WHO) recommends 1) initiation of breastfeeding 
within the first hour of birth 2) exclusive breastfeeding (EBF) for at least six-months 3) 
complementary breastfeeding (CBF) up to two years of age and 4) breastfeeding on demand 
(i.e. when the child wants).2,3 
 
EBF is defined as solely supplying infants with breast milk for proper growth and 
development since the milk will resource infants with 100% of the nutrients needed during 
those recommended first six months of life.2  As indicated in Figure 1, after the first six 
months of EBF, CBF is introduced and breast milk need not be used as the sole food-source, 
but as an addendum to the introduction of solid foods and alternative drink options to the 
infant's diet. It has been recommended that the consumption of breast milk in an older 
infant's diet changes to 50% for the second six months of life, and 33% during the second 
year of life.4 
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Figure 1: WHO Breastfeeding Recommendations Timeline   
 
 
 
 
 
Overall, in the United States (US), breastfeeding can prevent 823,000 child deaths 
and boost the economy by approximately $300 billion (0.49% gross income improvement 
globally). These health and fiscal benefits make breast milk superior to manufactured breast 
milk substitutions (BMS) (i.e. infant formula). Therefore, BMS should be used as a tool, not 
a precedence to EBF or CBF.5-8  
 
Although breastfeeding has seemingly infinite number of benefits, complications and 
frustrations can arise for the mother if their baby does not latch properly or if she is simply 
unable to breastfeed. When available, donor milk is a substitute for mothers who are not able 
to supply their children with their own breast milk for optimal nutrition.9 Therefore, mothers 
can avoid the added expense of BMS which only provides secondary nutritional levels 
compared to traditional breast milk. Donor milk is especially essential and practical during 
instances where the infant is preterm or ill.9 When donor milk is not an available practice, 
BMS can then be used to nourish the infant for adequate growth and development. 
 
Conversely, the aggressive promotion and marketing associated with the BMS 
industry has had a negative impact on overall breastfeeding practices. Unethical marketing 
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ploys in low- to middle- income countries (LMICs), including South Africa, by NestleTM 
(Appendix A) caused mothers to live outside of their monetary means and purchase formula. 
Mothers became hooked on the formula by creating goals of westernization and middle-class 
acceptance. LMIC mothers were triggered to dilute their baby formula and inadvertently 
deprive their baby of the necessary nutrients to stay alive, increasing infant mortality rates 
(IMRs).10 As seen in Figure 2 and Appendix A, South Africa had their highest IMRs during 
the  NestleTM scandal allegations in the early to mid-1970s.11 
 
Figure 2: World Bank’s Data on South Africa Infant Mortality Rates (1974 – 2018) 
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drink, like maize porridge and water, to ensure their baby’s adequate nutrition (i.e. CBF).12-14 
Moreover, the current WHO recommendation of EBF for at least six months does not align 
with current South African breastfeeding practices. In a research study examining SA 
mothers breastfeeding practices, none of the Peri-urban community mothers reported to EBF 
their infants; however, 78% reported CBF practices.12 
 
Sibeko et al. found other cultural beliefs such as the introduction of herbal 
preparations (occurring in 56% of their study population) were responsible for several CBF 
concerns.12 The mother's diet is ultimately the régime the infant will receive whether directly 
or via breast milk. Hence, outside influences on the mother's decision-making (i.e., the 
socioecological framework) must also be taken into consideration when understanding the 
mother's decision to initiate breastfeeding, EBF, or CBF.  
 
Generational knowledge and comprehension of breastfeeding mostly originates with 
clinical figures. If physicians were misinformed or inadequately translating information to 
patients, poor breastfeeding practices will recurrently circulate. Shah, Rollins, and Bland 
found that despite 92% of doctors South Africa knowing initiation should take place within 
30 minutes to one hour of delivery, other WHO recommendations such as EBF were not 
mandated (i.e. 71% recommend water, 50% recommend solids, and 57% recommended 
glucose water within the first six months of infancy).15 Difficulties associated with 
breastfeeding initiation and exclusivity rates also arise when hospitals and clinical care teams 
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are not breastfeeding-friendly environments (i.e. not initiating breastfeeding within the first 
30 minutes to one hour of delivery or supplying baby formula).  
 
South Africa is one of the most funded countries from President’s Emergency Plan 
for AIDS Relief (PEPFAR).16 Conversely, there is conflicting and lack of translating 
information to HIV-positive mothers regarding the transmission of HIV through breastmilk, 
causing mixed feeding practices amongst infected mothers.17,18 During the early stages of the 
HIV epidemic, infected mothers were generally discouraged from breastfeeding altogether if 
they met certain South African mandated criteria to safely provide alternative methods to 
nourish the infant.15 Many of the HIV-positive mothers did not meet said criteria. However, 
HIV-infected mothers have been shown to at least initiate breastfeeding and were more likely 
to initiate and report EBF compared to HIV-negative mothers.17, 19-21 
 
Further research is required to assess prevention methods regarding female cancer 
development and childhood ailments when comparing HIV-positive with HIV-negative 
mothers. However, EBF has been shown to reduce the likelihood of HIV transmission from 
mother to baby compared to CBF.22,23 
 
Breastfeeding Rates in South Africa 
Overall, despite low- (LIC), middle- (MIC), or high-income (HIC) status of a country,  
the vast majority of children (95%) have ever been breastfed with trends of never 
breastfeeding being lower in LICs and MICs (4%), like SA, compared to HICs (21%) (Figure 
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3).24 Although the general consensus is that LICs, MICs, and LMICs have higher 
breastfeeding rates than HICs, breastfeeding rates and duration vary between and within 
countries respective economic classifications. Nonetheless, the poorer the family, the higher 
the likelihood of the mother and baby indirectly abiding by WHO breastfeeding 
recommendations out of necessity to live within their means (Figure 4).25   
 
Figure 3: High-Income Countries vs. Low- and Middle-Income Countries’ Overall 
Breastfeeding Outlook Using 2018 UNICEF Data23 
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Figure 4: High-, Middle-, and Low-Income Countries’ Breastfeeding Variation at 2 years of 
age25 
 
 
 
South Africa’s mortality and birth rates (Figure 5) indicate the country is undergoing 
a phase in the demographic transition where developmental advancements are occurring 
while birth and death rates are simultaneously decreasing.26,27 Westernization influences the 
transformation of women’s roles in society into becoming more involved and having 
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increased responsibilities in the workplace. In response, breastfeeding practices have also 
evolved.  
 
The 2012 iteration of the South African Demographic and Health Survey (SADHS) 
stated a decrease in breastfeeding duration (5.9 months) with 35.8% of children being 
breastfeed for 12-15 months and 13.4% of children being breastfed for 20-23 months 
compared to 2003’s SADHS reports a breastfeeding median of 16.6 months.28 SA 
breastfeeding rates are highly dependent on the province and SES, as well as other factors 
that are specific to South African municipals, like HIV status and overall breastfeeding 
knowledge. 
 
Figure 5: South Africa’s Demographic Transition Modeled from Our World Bank 1950 
2015 Data26,27 
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South Africa has shown fluctuating breastfeeding rates throughout its history. Women 
have been reported to have very low EBF rates (7.4%) and high CBF (70-75%) rates before 6 
months of age.28 These breastfeeding rates directly coincide with the diverse racial and ethnic 
cultures which directly include breastfeeding practices within SA.12,15 
  
Breastfeeding and Breast Cancer 
Breastfeeding is known to have protective factors for the child who is consuming the 
breast milk, but proper breastfeeding practices can also be a prevention method for the 
mother as well. Health benefits include the risk reduction of estrogen-receptor (ER) related 
cancers (such as ovarian and estrogen-receptor-positive (ER+) breast cancer) and the 
prevention of 20,000 annual maternal-related breast cancer deaths in the US.4,6 
 
Almost all breast cancer develops in the ducts or the lobules, developing a pre-
cancerous lesion, ductal carcinoma in situ or DCIS.29 During lactation, both health and 
potentially damaged breast tissues are shed; thus, reducing the risk of breast cancer cell 
development.30 Moreover, the longer a woman lactates and breastfeeds, the more breast tissue 
cells will shed.  
 
After 12 months, breastfeeding can slightly reduce the risk of both pre- and post-
menopausal breast cancer by 4.3%.30,31 Mothers who breastfed for a combined duration of 2 
years, for all children, are expected to attain about twice the benefit of those who breastfed 
for a total of 1 year; whilst, mothers who breastfed for a lifetime total of more than two years 
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are expected to receive the most benefit with no significant difference for women in HICs 
compared to LMICs.31,32 
 
PUBLIC HEALTH SIGNIFICANCE 
 
Breast Cancer and the South African Healthcare System 
 
Breast carcinoma proliferative lesion of the breast tissue that has both genetic and 
environmental risk factors, varying within each patient. South Africa (SA) is currently 
experiencing increased rates of female cancers; specifically, breast carcinoma, with troubling 
trends towards later-stage diagnoses. In 2012, southern Africa had an incidence of 39 breast 
cancer cases per 100,000 women compared to 46.2 breast cancer cases per 100,000 women 
2018.33,34 This increase was predicted by Globocan and is assumed to be caused by 1) all 
forms of cancers are increasing in South Africa 2) healthcare resources are inadequate to 
meet this growing need 3) breast cancer is the most common cancer amongst SA women 4) 
most women in SA present with late-stage diagnoses.35-40 
 
Metastasis and lymph node spread is the major concern with breast cancer; otherwise, 
the disease can be mitigated, treated, and ultimately cured.41,42 The hindrance with later stage 
diagnosis in SA is the higher probability of being diagnosed with metastatic breast cancer 
and the inability to effectively treat or cure due to low resources; therefore, increasing the 
mortality rate.41,42 The mortalities of non-communicable diseases, like cancers, are a result in 
a shift away from pre-industrialization where infectious diseases are prominent, due to lack 
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of public health knowledge, and towards industrialization where chronic diseases are more 
prevalent, due to increases in technology, more advanced medical practices, and 
manufacturing.  
 
Moreover, healthcare resources are being heavily allocated to the infectious disease 
that are also burdening the SA healthcare system (i.e. tuberculosis (TB), human 
immunodeficiency virus (HIV), and acquired immunodeficiency syndrome (AIDS)), so 
breast cancer patients who are at risk of metastasis or who present with larger tumors at risk 
of metastasizing may not receive as urgent care and management as desired.44,45 
 
The proposed research aim, to evaluate the inverse association between breastfeeding 
history and breast cancer outcomes, will provide quantitative evidence to support policy 
decisions about how a low no-cost method (in terms of monetary value) may potentially aid 
in the reduction of the foreseeable increase of breast cancer incidence which is burdening the 
SA healthcare system. Using a method that is fiscally friendly is beneficial to LMICs like SA 
because it will prevent additional economic strain. Instead, breastfeeding will indirectly 
improve the economy because of breastfeeding’s additional healthcare benefits (i.e. reducing 
childhood mortality/morbidity, childhood obesity prevention, infectious and chronic disease 
prevention for both baby and mother).1,4,6  
SPECIFIC AIM 
Aim 
 
 
 
12 
 
• To evaluate the association between breastfeeding history and breast cancer diagnosis 
while controlling for clinically and statistically relevant confounders (i.e. age, 
enrollment date, breast cancer family history, HRT use, smoking ever-use, alcohol 
consumption, HIV status, and menopausal status).  
 
Hypothesis 
 
• There is an inverse association between breast cancer diagnosis and breastfeeding 
exposure in South African mothers; while controlling for all other factors (i.e. age, 
enrollment date, breast cancer family history, HRT use, smoking ever-use, alcohol 
consumption, HIV status, and menopausal status).  
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METHODS 
Study Design 
 
This pilot study implemented a hospital-based, nested case-control design. A 
retrospective medical chart review was conducted and evaluated the association between 
breastfeeding history (Y/N) of South African mothers in those who were diagnosed with 
breast cancer (cases) or discharged with mastalgia (controls). The analysis controlled for 
clinically and statistically relevant confounders including age, enrollment date, breast cancer 
family history, HRT use, smoking ever-use, alcohol consumption, HIV status, and 
menopausal status.  
 
Data was collected from a public hospital in Cape Town, Western Cape, South Africa 
during their Friday breast clinic where a combination of physician and pathology 
examinations were conducted, Monday telephone clinic where pathology results were given 
to patients from Friday’s breast clinic, and Wednesday Collaborative Breast Clinic (CBC) 
where women’s breast cancer care plan was discussed. 
 
Study Setting 
 
Data was collected at Groote Schuur Hospital (GSH) located in Cape Town, Western 
Cape, South Africa. GSH had a history of being a “Whites only” medical establishment 
during the Apartheid era but is now a government-funded public hospital who accepts all 
races, ethnicities, and patients with and without health insurance. Medical charts were 
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reviewed from patients who participated in the Friday breast clinic, Monday telephone clinic, 
or Wednesday CBC.  
 
Study Subjects 
 
GSH’s Breast Ward patient population primarily consists of women who were coded 
as H1, annual income < R36 000, of racial or ethnic origin, and deprived of health insurance. 
Study participants were breast cancer patients at Groote Schuur Hospital from May-August 
2019. Cases were diagnosed with breast cancer and required to meet the following inclusion 
criteria: 1) diagnosed with breast cancer; 2) a mother; 3) participated in GSH’s Friday breast 
clinic, Monday telephone clinic, or Wednesday CBC from May-August 2019; 4) female; 5) 
African native or citizen.  
 
Controls were defined as patients discharged with mastalgia and required to meet the 
following inclusion criteria: 1) patients who present with mastalgia and were not diagnosed 
with any other breast-related condition; 2) a mother; 3) participated in GSH’s Wednesday 
CBC, Friday breast clinic, or Monday telephone clinic from May-August 2019; 4) female; 5) 
African native or citizen.  
 
Overall motherhood status was included in this study to avoid ethical implication that 
may coincide with the title of a “mother”. Thus, this study also included patients who had 
miscarriages or have children through another equivalent avenue. To avoid having a large 
 
 
15 
 
number of young women in the control group, patients were matched 1:1 on month of visit. 
GSH had never had a patient under 20 years of age with breast cancer; therefore, the age 
inclusion range was set at ≥ 20 years old. Potential control subjects who were diagnosed with 
another benign diagnosis other than mastalgia were excluded from the study to avoid further 
skew, residual confounding, and extensive effect measure modification. 
 
Data Collection 
 
The data collection for this study uses GSH’s Breast Clinic’s RedCapTM database to 
collect cases and a retrospective medical chart review to collect controls. Cases and controls 
were matched 1:1 on clinical visit to take into account the later-stage diagnosis trend. Data 
were used to assess the association between breast cancer (outcome) and breastfeeding 
history (exposure) as well as other covariates and potential confounding factors, including 
age at clinical visit, breast cancer family history, HRT ever-use, smoking ever-use, alcohol 
consumption, HIV status, and menopausal status. Data collection for this study did not 
include personal health information or other identifiable factors.  
 
Data Analysis 
 
Univariate analysis including means and percentages were calculated to describe the 
patient population by outcome status; mastalgia patients (controls), and breast cancer patients 
(cases). Bivariate conditional logistic regression assessed the log odds difference in 
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continuous predictor variables (i.e. age at clinical visit, age of menarche, age at first delivery, 
and number of pregnancies) betweeen non-breast cancer and breast cancer groups; while, 𝜒𝜒2 
analysis assess difference amongst categorical predictor variables (i.e. breastfeeding history, 
breast cancer family history, HRT ever-use, HIV status, and menopausal status) between 
non-breast cancer  and breast cancer patient groups. 
 
A crude model was initially constructed to assess the bivariate association between 
the main exposure (breastfeeding history) and main outcome (breast cancer).  Mid data 
collection, medical forms were revised, removing alcohol consumption from the medical 
history collection; therefore, alcohol was not considered in the multivariable model building 
techniques due to inconsistent variability across the entire study period and population. 
Forward and backward variable inclusion/elimination was used to build the multivariable 
conditional logistic regression model. Both models had identical outcomes; therefore, AIC 
numbers were not needed to be taken into account for the best fit model.  
 
The final model resulted in age and age at first delivery being statically significant. 
Due to multicollinearity between the two covariates, age at first delivery was removed, 
leaving age to be controlled for in the adjusted model. Since family history and menopausal 
status have genetic and clinical associations with breast cancer outcomes, respectively, both 
predictor variables were considered for the multivariable model. However, age and 
menopausal status were highly correlated, leaving age and family history to be controlled for 
in the final multivariable conditional logistic regression model.  
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Effect measure modification was evaluated between age and family history using an 
interaction term; however, a significant association was not observed. Predicted probabilities 
of breast cancer was plotted against breastfeeding history and family history, across age 
progression using post-estimation graphing techniques.  
 
HUMAN SUBJECTS SAFETY CONSIDERATIONS  
 
Ethical Considerations  
 
Human Subjects ethics has been approved by the UTHealth Institutional Review 
Board (HSC-SPH-19-0263) and Groote Schuur Hospital’s Ethics Committee (IRB number: 
IRB00001938). All data were saved on a password-protected computer and were not 
distributed to or viewed by any person that is not on either IRB application. No identifiers 
were available in the dataset, neither individually, nor appended. 
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RESULTS 
Sample Description  
 Uni- and bivariate statistics of breast cancer cases and mastaglia discharged controls, 
matched on month, are presented in Table 1. In a sample of 360 South African mothers, 77% 
had a history of breastfeeding (main exposure) while 50% were diagnosed with breast cancer 
(main outcome) due to the 1:1 matching on clinic visit month. The majority of the mothers 
were not currently breastfeeding (99%) and post-menopausal (66%) which coincides with the 
age (mean= 53, SD= 14.23) of the patient population. The average age of menarche was 14 
(SD= 2.12), average age of delivery was 22 (SD= 5.10), and average number of pregnancies 
was 3 (SD= 1.60). South African mothers also reported to have marginally higher 
percentages of not having a family history of breast cancer (74%), no HRT ever-use (91%), 
to be non-smoking (63%), consume no alcohol (83%), and were HIV-negative (91%). 
 
Table 1: Description of Groote Schuur Hospital’s Breast Cancer Cases and Mastalgia 
Controls Matched on Month of Clinical Visit 
N= 360 N (%) 
  
Age at Clinical Visit (mean, SD) 53, 14.14 
Age of Menarche (mean, SD) 14, 2.12 
Age at First Delivery (mean, SD) 22, 5.10 
Number of Pregnancies (mean, SD) 3, 1.60 
Breastfeeding History  
(n=300)  
No 69 (23) 
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Yes 231 (77) 
Currently Breastfeeding  
(n=228)  
No 226 (99) 
Yes 3 (1) 
Family History of Breast Cancer  
(n=329)  
No 242 (74) 
Yes 87 (26) 
HRT ever-use  
(n=159)  
No 145 (91) 
Yes 14 (9) 
Smoking ever-use  
(n=319)  
No 201 (63) 
Yes 118 (37) 
Alcohol Consumption  
(n=220)  
No 182 (83) 
Yes 38 (17) 
HIV status 
(n=260)   
Negative 236 (91) 
Positive 16 (6) 
Not Done 8 (3) 
Menopausal Status  
(n=280)  
Pre-menopausal 71 (26) 
Peri-menopausal 21 (8) 
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Post-menopausal 185 (66) 
Breast Cancer  
(n=360) 
 
Yes 180 (50) 
No 180 (50) 
 
Bivariate analyses of predictor variables, matched on month of clinic visit, compared 
breast cancer and non-breast cancer diagnosed SA mothers (Table 2). The odds of breast 
cancer significantly increased by 0.0267 with each increase year of age (p=0.016). The 
statistical significance of age is visually represented by the mean age difference in non-breast 
cancer (mean age 50, SD= 13.04) versus breast cancer (mean age 57, SD= 15.51) diagnoses. 
There is also a statistical difference between HIV status amongst non-breast cancer and 
breast cancer diagnoses. When SA mothers whose HIV test was “not done” were replaced as 
missing, the statistical difference between positive and negative HIV status remained (p= 
0.045). However, age of menarche (p=0.704), age at first delivery (p=0.259), number of 
pregnancies (p= 0.961),  currently breastfeeding (p=0.533), family history of breast cancer 
(p=0.327), HRT ever-use (p= 0.567),  smoking ever-use (p=0.063),     alcohol consumption 
(p=  0.325), and menopausal status (p=0.433) showed no significance difference between 
breast cancer and non-breast cancer groups. 
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Table 2: Conditional Logistic Regression and 𝝌𝝌𝝌𝝌 Bivariate Analysis Comparing the Difference Between Breast Cancer Groups Amongst 
Predictor Variables 
N= 360 Non-Breast  
Cancer 
Breast 
Cancer 
Clogit 
(𝜷𝜷, p-value) 
𝝌𝝌𝝌𝝌  
p-value 
     
Age at Clinical Visit (mean, SD) 50, 13.04 57, 15.51 0.0267, 0.016 *  
Age of Menarche (mean, SD) 14, 2.13 13, 0 - 0.275, 0.704  
Age at First Delivery (mean, SD) 22, 4.78 23, 5.35 0.040, 0.259  
Number of Pregnancies (mean, SD) 3, 1.55 3, 1.65 0.005, 0.961  
Breastfeeding History  
(n=300)    0.358 
No 39 (25) 30 (21)   
Yes 116 (75) 115 (79)   
Currently Breastfeeding  
(n=228)    0.533 
No 71 (99) 155 (99)   
Yes 1 (1) 1 (1)   
Family History of Breast Cancer  
(n=329)    0.327 
No 120 (71) 122 (76)   
Yes 48 (29) 39 (24)   
HRT ever-use  
(n=159)    0.567 
No 84 (92) 61 (90)   
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Yes 7 (8) 7 (10)   
Smoking ever-use  
(n=319)    0.061 
No 94 (58) 107 (68)   
Yes 68 (42) 50 (32)   
Alcohol Consumption  
(n=220)    0.325 
No 68 (86) 114 (81)   
Yes 11 (14) 27 (19)   
HIV status 
(n=260)     < 0.0001* 
Negative 148 (91) 88 (90)   
Positive 14 (9) 2 (1)   
Not Done 0 (0) 8 (8)   
Menopausal Status  
(n=280)    0.413 
Pre-menopausal 41 (30) 33 (23)   
Peri-menopausal 11 (8) 10 (7)   
Post-menopausal 86 (62) 99 (70)   
SD= standard deviation; 𝝌𝝌𝝌𝝌 = chi-square; 𝜷𝜷= beta coefficient; clogit= conditional logistic regression 
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Conditional Logistic Models 
 
A bivariate conditional logistic regression model, grouped by month of clinic visit, 
was conducted to examine the crude odds of breast cancer diagnosis with breastfeeding 
history (Table 3). Breastfeeding is shown to have a positive association that is not 
statistically significant (OR= 1.50, 95% CI [0.71 – 3.16]). Therefore, although not 
statistically significant, South African mothers who have a history of breastfeeding have a 
50% higher odds of breast cancer compared to South African mothers who do not have a 
history of breastfeeding. 
 
Table 3: Unadjusted and Adjusted Conditional Odds of Breast Cancer with Breastfeeding 
History, While Controlling for Statistically and Clinically Relevant Covariates (i.e. Age at 
Clinical Visit and Family History of Breast Cancer) 
 Model 1 
OR (95% CI) 
Model 2 
AOR (95% CI) 
Breastfeeding History   
No Ref Ref. 
Yes 1.50 (0.71 – 3.16) 1.54 (0.69 – 3.43) 
Age at Clinical Visit --- 1.03 (1.01 – 1.06) 
Family History of Breast Cancer   
No --- Ref. 
Yes --- 1.04 (0.49 – 2.22) 
R2 0.0051 0.0400 
OR= unadjusted odds ratio; AOR= adjusted odds ratio; CI= confidence interval; age is measured in years; Ref.= 
reference group 
 
 Model 2 in Table 3 contains statistically relevant confounders (i.e. age) in addition 
to family history which is clinically relevant effect measure modifiers for breast cancer 
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outcomes. Although not statistically significant, the increased odds of breast cancer with 
breastfeeding history increased from 50% in the crude model to 54% (AOR= 1.54, 95% CI 
[0.69 – 3.43]) in the adjusted model when controlling for age at clinical visit and family history 
of breast cancer. In addition, SA mothers with a family history of breast cancer have 4% higher 
odds of being diagnosed with breast cancer (AOR= 1.04, 95% CI [0.49 – 2.22]), when 
controlling for breastfeeding and age at clinical visit. With each yearly increase in age, the 
odds of breast cancer significantly increased by 3% (AOR= 1.05, 95% CI [1.01 – 1.06]), when 
controlling for breastfeeding and family history of breast cancer.  
 
 The graphic display of the association between breastfeeding history and breast 
cancer diagnosis while controlling for age (Figure 7) shows an increased predicted probability 
as age increases. The overlap in the confidence intervals for both breastfeeding exposure 
categories (Y/N) represents the non-statistical significance of the association between the main 
exposure (breastfeeding history) and main outcome (breast cancer diagnosis). Figure 8 shows 
a different result where family history differences were not affected by age, but also had an 
increased breast cancer outcome and confidence interval overlap between exposure groups, 
illustrating the non-statistically significant from the 4% increased odds of breast cancer 
diagnosis. 
 
 
 
 
 
25 
 
Figure 6: Predicted Probability of Breast Cancer with Breastfeeding History While Controlling 
for Age 
 
 
 
Figure 7: Predicted Probability of Breast Cancer with Family History of Breast Cancer While 
Controlling for Age 
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DISCUSSION 
 
In this retrospective, nested case-control study that examined the association between 
breastfeeding history and breast cancer, results did not support a protective effect. 
Specifically, when assessing the direct relationship between breastfeeding history and breast 
cancer, South African mothers who have a history of breastfeeding have a 50% increase in 
odds of breast cancer compared to South African mothers who have no history of 
breastfeeding. The adjusted conditional logistic regression model also resulted in a positive 
relationship opposed to the hypothesized inverse association. When controlling for age at 
clinical visit and family history of breast cancer, South African mothers who have a history 
of breastfeeding have a 54% increased odds of breast cancer compared to not having a 
breastfeeding history. In favor of the unique characteristics within the patient population, 
neither of the cross-over effects were supported by previous literature outside of the South 
Africa setting, but is similar to literature that the same patient population attributes. 
Additionally, there is evidence of negative confounding by family history and age because of 
their influence in the odds of breast cancer in the adjusted model (Table3).  
 
This positive association may be due to the limitations associated with the study in 
the design phase. The true inverse association between breastfeeding history and breast 
cancer odds could be hidden in light of residual confounding caused by race and ethnicity in 
addition to detailed breastfeeding history. However, age (3%) and family history (4%) have 
long been shown to be associated with increased odds of breast cancer diagnoses in previous 
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studies and are well-established causal risk factors which is also supported in this research 
study.46-53 
 
Breast cancer and modern treatment methods are stigmatized in African communities. 
Therefore, information bias from recall and interviewer bias (i.e. patients hiding information) 
during the verbal genetic mapping process that is conducted in the SA healthcare system may 
be the source of the lack of statistical significance when assessing the association between 
family history and breast cancer outcomes.54,55 Further research such as a qualitative study 
identifying themes and patterns in patients who undergo genetic testing, in addition to the 
physicians who conduct the genetic testing would need to be conducted to further isolate and 
assess the non-significant association. 
 
Journal Article #1 
Title: Lactation and Breast Carcinoma Risk in a South African Population 
Target Journal: American Cancer Society  
 Demographically, most of South African women within the study sample (446 cases, 
1471 controls) were defined as “colored” and between 35-49 years of age. Furthermore, the 
majority of the population in both cases (83%) and controls (85%) had a history of 
breastfeeding (OR = 0.9, 95% CI [0.7-1.3]). However, cases had a higher age at first delivery 
(20-24 (47.7%)) compared to controls (<20 (43.6)).56 
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Concerning the effects of lactation duration and history on breast carcinoma 
diagnosis, results concluded all breastfeeding odds were close to or equivalent to having a 
null effect for those who had accumulated a total breastfeeding period of less than three years 
(i.e. never (Ref.), ever (OR= 0.9 [0.7 – 1.3]), < 1 year (OR= 0.9 [0.6 – 1.3]), 1 year (OR= 1.1, 
[0.7 – 1.6]), 2 years (OR= 1.0, [0.6 – 1.5])).56 Conversely, SA mothers who had a life-course 
of breastfeeding time of more than three years had a protective effect, although not 
statistically significant (i.e. 3-4 years (OR= 0.8 [0.5 – 1.2]), 5-6 years (OR+ 0.8, [0.5 – 1.4]), 
≥ 7 years (OR= 0.7, [0.4 – 1.3]).56 
 
The covariates of menopausal status (i.e. never (Ref.); ever (OR= 1.0 [ 0.7 – 1.4]), 
number of children (i.e. none (Ref.), 1 (OR= 0.9, [0.6 – 1.3]), 2 (OR= 0.9 [0.6 – 1.3]), 3 
(OR= 1.0, [0.6, 1.5]), 4 (OR= 1.0, [0.6 – 1.6]), 5 (OR= 1.3, [0.7 – 2.3])), and age at fist 
lactation (i.e. never (Ref.),  ≤ 18 (OR= 0.7 [0.5 – 1.1]), 19 – 20 (OR= 0.8 [0.6 – 1.2]), 21 – 24 
(OR= 1.0, [0.7 – 1.4]), 25 – 29 (OR= 1.1, [0.8 – 1.7]), ≥ 30 (OR= 1.2, [0.7 – 2.1])) were also 
observed to have a null effect on breast cancer odds.56 
 
Both this research study and Coogen et al.’s study was conducted in the form of a 
hospital-based, case-control design. However, Coogen et al. did not use a defined cohort for a 
nested case-control study design. The patient populations were similar in the sense that 
majority of women in both samples of mothers ever breastfed and the difference amongst 
breastfeeding groups were not statistically significant (i.e. 83% cases and 85% controls (OR 
= 0.9, 95% CI [0.7-1.3]) in Coogen et al. versus 79% cases and 75% controls (p= 0.358)).56  
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While both research studies failed to obtain an inverse association between 
breastfeeding exposure and breast cancer outcomes, this study resulted in a cross-over effect 
while Coogen et al.’s research study concluded a null effect respective to WHO guidelines 
(AOR= 1.54, 95% CI [0.69 – 3.43]; (1 year (OR= 1.1, [0.7 – 1.6], respectively).56 The 
difference in concluding a null versus a positive association may be because Coogen et al.’s 
was able to obtain more detailed breastfeeding information (i.e. lactation duration). However, 
neither study was able to collect exclusivity versus complementary breastfeeding data which 
is essential is observing protective effects of breast milk for mothers.  
 
Additionally, neither study included race and ethnicity in their final logistic model. 
This research study was not able to collect said data points while Coogen et al. omitted the 
variable due to ambiguity regarding the definition of the racial and ethnic terms used in 
South Africa. In addition, this study was also not able to collect breastfeeding duration 
information. Therefore, there may be residual confounding in both studies due to race, 
ethnicity, and more specific breastfeeding history data points. 
 
Journal Article #2 
Title: Prevalence of Comorbidities in Women with and Without Breast Cancer in 
Soweto, South Africa: Results from the SABC study 
Target Journal: South African Medical Journal 
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The research study observing the effects of comorbidities on breast cancer was 
conducted in a matched case-control design. The 798 Black, South African women who 
participated in this study (mean age= 54.6, SD= 12.9) were categorized into two groups 1) 
advanced stage breast cancer cases 2) age and neighborhood match non-breast cancer 
controls.57 Similar to this research study, majority of the population in Ayeni et al.’s study 
was HIV-negative (i.e. 90% cases and 91% controls versus 83.5% cases and 77.4% controls, 
respectively).57 
 
Women with HIV had a significantly higher odds of presenting with advanced stage 
breast cancer compared to women without HIV (OR= 1.75, 95% CI [1.01 – 2.99]).57 
Furthermore, women who were HIV-positive have 1.44 [0.80 – 2.57] times the odds of 
presenting with advanced stage breast cancer compared to women who were HIV-negative, 
when controlling for age, household income, dyslipidemia, and hypertension.57 
 
While Ayeni et al.’s study does not examine lactation history, it does take into 
account the effects of HIV on breast cancer. Comparable to Ayeni et al.’s study (p=0.032), 
this study observed a statistical difference (p= < 0.001) amongst HIV groups (negative, 
positive, not done) between breast cancer and non-breast cancer.57 However, HIV was 
considered in the final model of this study due to lack of statistical significance. Therefore, 
the impact of HIV on breast cancer odds was not observed.57 
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Limitations 
 
The theorized association between breastfeeding and the reduced risk of breast cancer 
has been studied for decades. The inverse association is a result of ovulation suppression 
from lactation, which lowers estrogen levels and suppresses the food supply of ER+ breast 
cancers. Also, when mothers breastfeed, they shed breast tissue cells, including those that 
may be cancerous. Therefore, lactation duration is an important aspect when considering the 
reduced risk of breast cancer. Critical data collection elements were not collected to make the 
inverse association between breastfeeding history and breast cancer (i.e. breastfeeding 
duration, initiation, exclusivity, and complementary).  
 
The original study protocol was modified to a retrospective format for GSH Ethics 
Committee approval; therefore, eliminating the ability to collect detailed breastfeeding data 
along with accompanying qualitative interviews with staff and patients regarding the SA 
healthcare system. Collection of race and ethnicity data was also rejected and caused cultural 
interpretations and genetic dissimilarities about breastfeeding effects and practices to be 
combined; thus, leaving room for ambiguity in breastfeeding history and constituting 
variability. In addition, there are research gaps regarding the inverse association between 
breast carcinoma and lactation in South African women; nonetheless, previous studies in a 
South African failed to form an inverse relationship. Stratifying breastfeeding history and 
endocrinology data by race, ethnicity, and breastfeeding category, would enhance the 
comprehension of South African breastfeeding culture, effects, and breast cancer burden. 
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CONCLUSION 
Although the inverse association between breastfeeding history and breast cancer 
outcome was not observed, this pilot study provides credible research in support of the 
evidence-based theory that race, ethnicity, and detailed exposure-outcome status information 
is vital when observing the association of chronic diseases. Especially when dealing with 
scopes of practices and subject matters like cancers which is affected by a combination of 
genetic, environmental, and behavioral practices. 
 
Future Research 
There are significant gaps in the field regarding South African women and breast 
carcinoma overall. Innovative solutions to the limitations of this study may include: a 
multidisciplinary team consisting of SA surgical leaders, oncologists, and physicians within 
the breast and OBGYN wards, where data collection will occur, will collaborate on the study 
protocol. New chart forms will be curated to include breastfeeding details (initiation, 
duration, exclusivity, and complimentary) within the present endocrinology subsection to 
ease data collection processes, especially considering multiple languages (i.e. Afrikaans, 
Xhosa, and English). World Health Organization (WHO) breastfeeding regulations will be 
used for consistent and accurate recordings. Qualitative methods will also need to be 
included in a future study to better understand the patient population for appropriately 
tailored data collection procedures and, if needed, intervention programs. 
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APPENDICES 
Appendix A:  Nestle` Formula Push Scandal Timeline10 
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